Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All ivermectin studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19ivm.org COVID-19 treatment researchIvermectinIvermectin (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Paxlovid Meta
Famotidine Meta Quercetin Meta
Favipiravir Meta Remdesivir Meta
Fluvoxamine Meta Thermotherapy Meta
Hydroxychlor.. Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Why COVID-19 is not so spread in Africa: How does Ivermectin affect it?

Tanioka et al., medRxiv, doi:10.1101/2021.03.26.21254377
Mar 2021  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Mortality 88% Improvement Relative Risk Ivermectin for COVID-19  Tanioka et al.  Prophylaxis Is prophylaxis with ivermectin beneficial for COVID-19? Ecological study in multiple countries Lower mortality with ivermectin (p=0.002) c19ivm.org Tanioka et al., medRxiv, March 2021 Favorsivermectin Favorscontrol 0 0.5 1 1.5 2+
Ivermectin for COVID-19
4th treatment shown to reduce risk in August 2020
 
*, now with p < 0.00000000001 from 104 studies, recognized in 23 countries.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,400+ studies for 79 treatments. c19ivm.org
Retrospective study of the 31 onchocerciasis-endemic countries using the community-directed treatment with ivermectin (CDTI) and the 22 non-endemic countries in Africa, showing significantly lower mortality per capita in the countries using ivermectin.
This is the 45th of 104 COVID-19 controlled studies for ivermectin, which collectively show efficacy with p<0.0000000001 (1 in 1 sextillion).
51 studies are RCTs, which show efficacy with p=0.00000015.
This study is excluded in the after exclusion results of meta analysis: not a typical trial, analysis of African countries that used or did not use ivermectin prophylaxis for parasitic infections.
risk of death, 88.2% lower, RR 0.12, p = 0.002, relative mean mortality per million.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Tanioka et al., 26 Mar 2021, retrospective, ecological study, multiple countries, preprint, 3 authors, dosage 200μg/kg, dose varied, typically 150-200μg/kg.
This PaperIvermectinAll
Why COVID-19 is not so spread in Africa: How does Ivermectin affect it?
Hisaya Tanioka, Sayaka Tanioka, Kimitaka Kaga
doi:10.1101/2021.03.26.21254377
Background: Scientists have so far been unable to determine the reason for the low number of COVID-19 cases in Africa. Objective: To evaluate the impact of ivermectin interventions for onchocerciasis on the morbidity, mortality, recovery, and fatality rates caused by COVID-19. Method: A retrospective statistical analysis study of the impact of ivermectin against COVID-19 between the 31 onchocerciasis-endemic countries using the community-directed treatment with ivermectin (CDTI) and the non-endemic 22 countries in Africa. The morbidity, mortality, recovery rate, and fatality rate caused by COVID-19 were calculated from the WHO situation report in Africa. We investigated the onchocerciasis endemic 31 countries and the non-endemic 22 countries. Statistical comparisons used by the Welch test of them in the two groups were made. Results: The morbidity and mortality were statistically significantly less in the 31 countries using CDTI. The recovery and fatality rates were not statistically significant difference. The average life expectancy was statistically significantly higher in the non-endemic countries. Conclusions: The morbidity and mortality in the onchocerciasis endemic countries are lesser than those in the non-endemic ones. The community-directed onchocerciasis treatment with ivermectin is the most reasonable explanation for the decrease in morbidity and fatality rate in Africa. In areas where ivermectin is distributed to and used by the entire population, it leads to a significant reduction in mortality.
H.T. and S.T. analyzed the data and wrote the first draft. All authors provided critical revisions. All authors contributed equally to this study and approved the submitted manuscript.
References
Ahmed, Karim, Ross, A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness, Int J Infect Dis, doi:10.1016/j.ijid.2020.11.191
Canga, Prieto, Liébana, The Pharmacokinetics and Interactions of Ivermectin in Humans-A Mini-review, AAPS, doi:10.1208/s12248-007-9000-9
Iqbal, Abid, Hussain, The effects of regional climatic condition on the spread of COVID-19 at global scale, Sci Total Environ, doi:10.1016/j.scitotenv.2020.140101
Malik, Ansari, Ganesh, BCG vaccine: a hope to control COVID-19 pandemic amid crisis, Hum Vaccin Immunother, doi:10.1080/21645515.2020.1818522
Mehta, Mytton, Mullins, SARS-CoV-2 (COVID-19): What Do We Know About Children? A Systematic Review, Clin Infect Dis, doi:10.1093/cid/ciaa556
{ 'institution': [{'name': 'medRxiv'}], 'indexed': {'date-parts': [[2024, 3, 1]], 'date-time': '2024-03-01T23:50:51Z', 'timestamp': 1709337051255}, 'posted': {'date-parts': [[2021, 3, 26]]}, 'group-title': 'Infectious Diseases (except HIV/AIDS)', 'reference-count': 12, 'publisher': 'Cold Spring Harbor Laboratory', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'accepted': {'date-parts': [[2021, 3, 26]]}, 'abstract': '<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Scientists ' 'have so far been unable to determine the reason for the low number of COVID-19 cases in ' 'Africa.</jats:p></jats:sec><jats:sec><jats:title>Objective</jats:title><jats:p>To evaluate ' 'the impact of ivermectin interventions for onchocerciasis on the morbidity, mortality, ' 'recovery, and fatality rates caused by ' 'COVID-19.</jats:p></jats:sec><jats:sec><jats:title>Method</jats:title><jats:p>A retrospective ' 'statistical analysis study of the impact of ivermectin against COVID-19 between the 31 ' 'onchocerciasis-endemic countries using the community-directed treatment with ivermectin ' '(CDTI) and the non-endemic 22 countries in Africa. The morbidity, mortality, recovery rate, ' 'and fatality rate caused by COVID-19 were calculated from the WHO situation report in Africa. ' 'We investigated the onchocerciasis endemic 31 countries and the non-endemic 22 countries. ' 'Statistical comparisons used by the Welch test of them in the two groups were ' 'made.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The morbidity and ' 'mortality were statistically significantly less in the 31 countries using CDTI. The recovery ' 'and fatality rates were not statistically significant difference. The average life expectancy ' 'was statistically significantly higher in the non-endemic ' 'countries.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>The ' 'morbidity and mortality in the onchocerciasis endemic countries are lesser than those in the ' 'non-endemic ones. The community-directed onchocerciasis treatment with ivermectin is the most ' 'reasonable explanation for the decrease in morbidity and fatality rate in Africa. In areas ' 'where ivermectin is distributed to and used by the entire population, it leads to a ' 'significant reduction in mortality.</jats:p></jats:sec>', 'DOI': '10.1101/2021.03.26.21254377', 'type': 'posted-content', 'created': {'date-parts': [[2021, 3, 26]], 'date-time': '2021-03-26T21:50:34Z', 'timestamp': 1616795434000}, 'source': 'Crossref', 'is-referenced-by-count': 1, 'title': 'Why COVID-19 is not so spread in Africa: How does Ivermectin affect it?', 'prefix': '10.1101', 'author': [ {'given': 'Hisaya', 'family': 'Tanioka', 'sequence': 'first', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-4288-5332', 'authenticated-orcid': False, 'given': 'Sayaka', 'family': 'Tanioka', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kimitaka', 'family': 'Kaga', 'sequence': 'additional', 'affiliation': []}], 'member': '246', 'reference': [ { 'key': '2021032906250911000_2021.03.26.21254377v1.1', 'unstructured': 'Age, Sex, Existing Conditions of COVID-19 Cases and Deaths-Worldometer. ' 'Available at ' 'https://www.worldometers.info/coronavirus/coronavirus-age-sex-demographics/ ' 'Accessed February. 18, 21.'}, { 'key': '2021032906250911000_2021.03.26.21254377v1.2', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/cid/ciaa556'}, { 'key': '2021032906250911000_2021.03.26.21254377v1.3', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.scitotenv.2020.140101'}, { 'key': '2021032906250911000_2021.03.26.21254377v1.4', 'doi-asserted-by': 'publisher', 'DOI': '10.1080/21645515.2020.1818522'}, { 'key': '2021032906250911000_2021.03.26.21254377v1.5', 'unstructured': 'IVERMECTIN —A Potential global solution to the COVID-19 pandemic. FLCCC ' 'Alliance · October 31, 2020. Available at ivermectin_1.pdf ' '(kitasato-infection-control.info) Accessed February 27, 2021.'}, { 'key': '2021032906250911000_2021.03.26.21254377v1.6', 'unstructured': 'WHO | Regional Office for Africa. Onchocerciasis. Available at ' 'https://www.afro.who.int/health-topics/onchocerciasis'}, { 'key': '2021032906250911000_2021.03.26.21254377v1.7', 'unstructured': 'WHO | African Programme for Onchocerciasis Control (APOC). Available at ' 'https://www.who.int/apoc/cdti/en/'}, { 'key': '2021032906250911000_2021.03.26.21254377v1.8', 'unstructured': 'United Nations: Population and Vital Statistics Report. Population, ' 'latest available census, and estimates, latest available data. (Last ' 'Updated: 15 January 2021) Available at ' 'https://unstats.un.org/unsd/demographic-social/products/vitstats/seratab2.pdf'}, { 'key': '2021032906250911000_2021.03.26.21254377v1.9', 'unstructured': 'Weekly epidemiological update - 19 January 2021. WHO African Region. ' 'Available at ' 'https://www.who.int/publications/m/item/weekly-epidemiological-update ' '19-january-2021'}, { 'key': '2021032906250911000_2021.03.26.21254377v1.10', 'doi-asserted-by': 'publisher', 'DOI': '10.1208/s12248-007-9000-9'}, { 'key': '2021032906250911000_2021.03.26.21254377v1.11', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.ijid.2020.11.191'}, { 'key': '2021032906250911000_2021.03.26.21254377v1.12', 'unstructured': 'South Africa Government News Agency. SAHPRA approves Ivermectin for ' 'controlled human use. Available at ' 'https://www.sanews.gov.za/south-africa/sahpra-approves-ivermectin-controlled-human-use'}], 'container-title': [], 'original-title': [], 'link': [ { 'URL': 'https://syndication.highwire.org/content/doi/10.1101/2021.03.26.21254377', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2021, 3, 29]], 'date-time': '2021-03-29T13:25:20Z', 'timestamp': 1617024320000}, 'score': 1, 'resource': {'primary': {'URL': 'http://medrxiv.org/lookup/doi/10.1101/2021.03.26.21254377'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 3, 26]]}, 'references-count': 12, 'URL': 'http://dx.doi.org/10.1101/2021.03.26.21254377', 'relation': {'has-review': [{'id-type': 'doi', 'id': '10.32388/808354', 'asserted-by': 'object'}]}, 'published': {'date-parts': [[2021, 3, 26]]}, 'subtype': 'preprint'}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit